PMHNP Practice Authority in North Dakota: Independence, Physician Agreements and Schedule II

AANP's May 2026 map puts North Dakota in its full practice tier.

The label is AANP's advocacy classification; the legal fact behind it is the Board of Nursing's scope rule, which lists among the services APRN practice may include prescribing a therapeutic regimen of health care — diagnosing, prescribing, administering and dispensing legend drugs and controlled substances.

Nothing in the scope rule conditions practice on a physician's involvement, and the chapter's statement of intent frames the APRN as responsible and accountable for that scope of practice within the Nurse Practices Act.

For a job seeker, that is the text an employer's credentialing committee will be reading too.

North Dakota has no transition-to-practice period, and the licensure rule shows why none is needed: initial APRN licensure requires a current RN licence in North Dakota or a compact state, an accredited graduate APRN program, current national certification, no encumbered licence or privilege to practise in any state or territory, a notarized application with the fee, and certification that scope of practice is consistent with education and certification — no practice hours.

Prescriptive authority is documentary too: a transcript with the degree posted showing advanced pharmacotherapy, physical assessment and pathophysiology, plus thirty contact hours of education or equivalent in pharmacotherapy obtained within the three years immediately before the application, unless the board approves something else.

A new graduate counts no supervised-practice clock here; the sequence runs degree, certification, licence, then the prescriptive-authority application.

The chapter contains no collaborative agreement, no physician ratio, no meeting cadence, no chart-review percentage and nothing filed with a medical board.

Rule 54-05-03.1-12 — its title is Change in Physician Collaboration Regarding Prescriptive Authority, so it governed changes to an existing collaboration — is repealed effective October 1, 2011, and the Prescriptive Authority Review Committee (54-05-03.1-08) was repealed the same day.

The saved text does not show where any original collaboration requirement itself lived; what it shows is the current chapter's absence — no collaboration requirement appears anywhere in the text read, and no physician signature is required by the application or prescribing rules.

For an associate weighing offers, there is no supervisory relationship to negotiate and no employer-side agreement the law requires.

The prescribing rule is schedule-neutral: an APRN with prescriptive authority may prescribe drugs under state and federal law, and may prescribe, administer, sign for and dispense over-the-counter, legend and controlled substances.

No Schedule II day-supply cap, setting restriction or physician-consult requirement appears in the chapter, so an outpatient North Dakota PMHNP can prescribe Schedule II ADHD stimulants.

What attaches is procedure: each licensee must hold a DEA number before writing controlled-substance prescriptions; prescription drug monitoring program reports must be evaluated and documented for a new controlled-substance client, every six months during treatment, on early refills or a pattern of taking more than prescribed, and on suspicion of overuse, diversion or abuse; controlled substances may not be prescribed to oneself, one's spouse or one's child; and signatures must identify the prescriber as an APRN.

A separate state controlled-substance registration was not located in the sources read — the rule requires the federal DEA number.

North Dakota's own limits are about who and what, not how much.

Each APRN documents with the designation APRN plus the applicable role designation, and the roles include certified nurse practitioner with population foci that include psychiatric mental health.

Scope must be consistent with the APRN's nursing education and certification, and services must be commensurate with the licensee's academic preparation, experience, continuing education and demonstrated competencies.

On the federal layer, the state licence does not include DEA authority — each licensee applies for a DEA number separately, and that registration covers only what North Dakota allows.

The DEA and HHS telemedicine flexibilities, extended through December 31, 2026, remove the federal in-person visit requirement for remote Schedule II to V prescribing; they lift no state limit, and the chapter sets none to lift.

North Dakota is among the compact's five enacting states as of September 2026, alongside Delaware, South Dakota, Utah and Wyoming, with the enacted text codified at chapter 43-12.5.

It is not in effect: the compact comes into limited effect only when enacted in seven party states, so no APRN holds a multistate APRN licence today.

When it takes effect, a multistate licence will require at least two thousand eighty hours of practice as an APRN in a role and population focus congruent with the licensee's education and training, and practice during the education program itself does not count.

The multistate licence would carry prescriptive authority for non-controlled drugs, while controlled-substance authority in each state still runs through that state's own requirements.

The enacting session-law year is not shown in the chapter PDF and was not located.

The research section records no 2023–2026 changes.

The prescriptive-authority requirements rule, 54-05-03.1-09, was last amended effective July 1, 2020, and the authority-to-prescribe rule, 54-05-03.1-10, was last amended effective October 1, 2016, by their own history notes.

Rule 54-05-03.1-12, which governed changes in physician collaboration regarding prescriptive authority, has been repealed since October 1, 2011, and no collaboration requirement appears in the chapter as read.

Whether a bill affecting APRN practice authority moved in the most recent legislative session was not researched, so check the North Dakota Legislature before assuming the text is unchanged.

A first-time certification exam candidate who holds a current RN licence and has submitted a complete application, the required fee and evidence of meeting all educational requirements may be issued a ninety-day temporary APRN permit while awaiting results — the rule says may, and the permit carries no prescriptive authority.

Full APRN licensure follows on the chapter's requirements: a current RN licence in North Dakota or a compact state, an accredited graduate APRN program, current national certification, no encumbered licence or privilege to practise in any state or territory, certification that scope matches education and certification, and a notarized application with a one hundred twenty-five dollar fee.

The prescriptive-authority application is separate, at seventy-five dollars, and the permanent APRN licence with prescriptive authority issues once all of it is met.

Both renew on the RN licence cycle: an eighty dollar APRN renewal plus a seventy-five dollar prescriptive-authority renewal, with evidence of current national certification and fifteen contact hours of pharmacotherapy in the previous two years — hours that may also count toward the RN continuing-education requirement.